MCH ADVISORY RESEARCHMain site ↗
Information Technology

Application Software

26 companies under coverage.

Coverage

Application Software


Equity Research

Applovin Corp (APP)

BUY. 12-month probability-weighted target $482 (+54% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

APPEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +25.0%
Equity Research

Fair Isaac Corporation (FICO)

BUY. 12-month probability-weighted target $1155 (+24% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

FICOEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +22.4%
Equity Research

Cadence Design Systems Inc (CDNS)

BUY. 12-month probability-weighted target $379 (+33% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

CDNSEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +13.0%
Equity Research

Synopsys Inc (SNPS)

HOLD. 12-month probability-weighted target $451 (+15% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

SNPSEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +7.4%
Equity Research

Pegasystems Inc (PEGA)

SELL. 12-month probability-weighted target $32 (-12% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

PEGAEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -1.5%
Equity Research

Autodesk Inc (ADSK)

SELL. 12-month probability-weighted target $195 (-8% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

ADSKEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -1.9%
Equity Research

Bentley Systems Inc (BSY)

HOLD. 12-month probability-weighted target $33 (+0% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

BSYEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -4.0%
Equity Research

Dolby Laboratories (DLB)

SELL. 12-month probability-weighted target $52 (-17% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

DLBEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -4.3%
Equity Research

Adobe Systems Incorporated (ADBE)

SELL. 12-month probability-weighted target $202 (-21% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

ADBEEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -5.4%
Equity Research

Guidewire Software Inc (GWRE)

HOLD. 12-month probability-weighted target $150 (+0% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

GWREEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -6.0%
Equity Research

Dynatrace Holdings LLC (DT)

SELL. 12-month probability-weighted target $45 (-10% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

DTEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -6.5%
Equity Research

Intuit Inc (INTU)

SELL. 12-month probability-weighted target $252 (-21% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

INTUEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -6.9%
Equity Research

Bill Com Holdings Inc (BILL)

HOLD. 12-month probability-weighted target $44 (-7% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

BILLEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -8.3%
Equity Research

DocuSign Inc (DOCU)

SELL. 12-month probability-weighted target $54 (-17% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

DOCUEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -8.3%
Equity Research

PTC Inc (PTC)

SELL. 12-month probability-weighted target $117 (-12% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

PTCEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -9.0%
Equity Research

Oracle Corporation (ORCL)

HOLD. 12-month probability-weighted target $148 (-9% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

ORCLEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -12.3%
Equity Research

Trimble Inc (TRMB)

SELL. 12-month probability-weighted target $49 (-17% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

TRMBEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -13.0%
Equity Research

Datadog Inc (DDOG)

HOLD. 12-month probability-weighted target $240 (+14% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

DDOGEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -13.3%
Equity Research

Tyler Technologies Inc (TYL)

SELL. 12-month probability-weighted target $279 (-20% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

TYLEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -15.2%
Equity Research

Dropbox Inc (DBX)

SELL. 12-month probability-weighted target $30 (-12% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

DBXEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -18.3%
Equity Research

Okta Inc (OKTA)

SELL. 12-month probability-weighted target $148 (-12% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

OKTAEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -18.5%
Equity Research

Manhattan Associates Inc (MANH)

SELL. 12-month probability-weighted target $167 (-20% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

MANHEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -21.2%
Equity Research

Palantir Technologies (PLTR)

SELL. 12-month probability-weighted target $139 (-18% vs spot). P/E Multiple explains 90% of Monte Carlo outcome variance.

PLTREquity ResearchMonte Carlo
9 September 2026Rating: SELL · -27.1%
Equity Research

Workday Inc (WDAY)

SELL. 12-month probability-weighted target $119 (-36% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

WDAYEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -32.3%
Equity Research

Salesforce.com Inc (CRM)

SELL. 12-month probability-weighted target $157 (-37% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

CRMEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -39.0%
Equity Research

Appfolio Inc (APPF)

SELL. 12-month probability-weighted target $77 (-63% vs spot). Gross Margin explains 58% of Monte Carlo outcome variance.

APPFEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -70.2%
MCH ADVISORY SERVICES · All research · Research, not personalised investment advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed